MOD-000001, a novel orally available KIT inhibitor with efficacy in models of allergic disease
March 1, 2023
It has been demonstrated that stem cell factor (SCF) and its receptor KIT play key roles in the differentiation, proliferation, survival, migration and activation of mast cells, which in turn play a central role in the development of IgE-mediated allergic diseases, including allergic urticaria and food allergy.